Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: October 6, 2026 at 10:59 PM UTC
| NCT Number | NCT06590857 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 64 participants |
| Active Locations | 25 sites in the US |
| Sponsor | RayzeBio, Inc. |
| Last Updated on CT.gov | October 6, 2026 (22 hours ago) |
As of October 6, 2026: Clinical trial NCT06590857 is currently recruiting participants. This phase1 study for breast cancer is actively seeking new participants at 25 locations across the United States. The study is sponsored by RayzeBio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06590857 is actively recruiting participants as of October 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06590857 was last updated 22 hours ago (October 6, 2026). HelloStudys verifies this status automatically.